Affiliation:
1. North-Western State Medical University named after I. I. Mechnikov
Abstract
The article highlights the modern understanding of etiology, epidemiology and pathogenesis of atrial fibrillation and flutter and their global burden as the most frequent form of supraventricular sustained tachyarrhythmia. The recent international and Russian national clinical guidelines on the treatment and prevention of atrial fibrillation are briefly discussed. The new antiarrhythmic drugs, presented in recent guidelines are also highlighted. The authors analyze their own experience in the treatment of paroxysmal atrial fibrillation with IC class drugs (propafenone) at the prehospital stage.
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Reference42 articles.
1. Atrial fibrillation and flutter. Clinical guidelines. Russian Society of cardiology, 2020. Available on the website RKO: www.scardio.ru (In Russ.).
2. Hindricks G., Potpara P., Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation // Eur. Heart J. 2020. Vol. 00. Р. 1–126. doi:10.1093/eurheartj/ehaa612
3. Kushakovsky M.S., Grishkin Yu. N. Heart arrhythmias. St. Petersburg: Рublishing house Foliant, 2020, 720 p. (In Russ.).
4. Plavunov N.F., Gaponova N.I., Kadishev V. A et al. Clinical and statistical analysis of patients with atrial fibrillation. Archive of internal medicine, 2018, Vol. 8, No. 5, pp. 389–393 (In Russ.). doi: 10.20514/2226-6704-2018-8-5-389-393.
5. Staerk L., Sherer J.A., Ko D. et. al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes // Circulation Res. 2017. Vol. 120. P. 1501–1517.